Should we test for genotype in deciding on age-related eye disease study supplementation?

@article{Wittes2015ShouldWT,
  title={Should we test for genotype in deciding on age-related eye disease study supplementation?},
  author={Janet T Wittes and David C. Musch},
  journal={Ophthalmology},
  year={2015},
  volume={122 1},
  pages={3-5}
}
When we, a 71-year-old white woman and a 60-year-old white man, both nonsmokers, have our eyes examined, we will want to know whether we classify as Age-Related Eye Disease Study (AREDS) category 3, and therefore would likely benefit from taking the AREDS supplement, which contains high-dose antioxidants (b-carotene, vitamin C, and vitamin E) plus high-dose zinc. As a statistician (J.W.) who chaired the AREDS and AREDS2 Data Safety Monitoring Committee and an epidemiologist (D.C.M.) who… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Macular disease genetics and supplementation: the evidence for choosing wisely.

Clinical & experimental ophthalmology • 2016
View 2 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…